URGN Stock Summary and Trading Ideas (Urogen Pharma Ltd. - | NASDAQ:URGN)

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in innovative solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

Urogen Pharma Ltd. - trades on the NASDAQ stock market under the symbol URGN.

As of April 25, 2024, URGN stock price declined to $13.98 with 17,294 million shares trading.

URGN has a beta of 1.68, meaning it tends to be more sensitive to market movements. URGN has a correlation of 0.03 to the broad based SPY ETF.

URGN has a market cap of $477.03 million. This is considered a Small Cap stock.

Last quarter Urogen Pharma Ltd. - reported $24 million in Revenue and -$.72 earnings per share. This beat revenue expectation by $960,000 and missed earnings estimates by -$.04.

In the last 3 years, URGN stock traded as high as $24.13 and as low as $4.85.

The top ETF exchange traded funds that URGN belongs to (by Net Assets): IWM, IBB, IWO, IZRL, SPDW.

URGN has underperformed the market in the last year with a return of +21.0%, while the SPY ETF gained +22.5%. In the last 3 month period, URGN fell short of the market, returning -7.0%, while SPY returned +3.1%. However, in the most recent 2 weeks URGN has outperformed the stock market by returning +8.0%, while SPY returned -3.0%.

URGN support price is $13.54 and resistance is $14.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that URGN stock will trade within this expected range on the day.